These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4644887)

  • 1. Acute reversible neurological manifestations due to triflupromazine therapy. A report of three cases.
    Doshi HV; Shah SS; Mehta RM
    Indian J Med Sci; 1972 Jun; 26(6):395-8. PubMed ID: 4644887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Four cases of extrapyramidal effects following the treatment of hyperemesis gravidarum with triflupromazin (author's transl)].
    Walter H
    Z Geburtshilfe Perinatol; 1976 Apr; 180(2):163-6. PubMed ID: 936714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extrapyramidal motoric symptoms and EEG changes following application of phenothiazine derivatives].
    Schiefer I
    Arch Kinderheilkd; 1971 Jul; 183(2):163-70. PubMed ID: 5567031
    [No Abstract]   [Full Text] [Related]  

  • 4. Akathesia with triflupromazine therapy in a young child.
    Prasan NG; Ghowdhry RM
    Indian Pediatr; 1965 Nov; 2(11):421-4. PubMed ID: 5865777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pseudotetanus following phenothiazine therapy].
    Matthes H; Andree G
    Zentralbl Chir; 1968 Jan; 93(4):147-9. PubMed ID: 5658295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tetany, hysterical attack or side-effect of therapy?].
    Michaelis R
    Med Klin; 1966 Mar; 61(12):471-3. PubMed ID: 5985033
    [No Abstract]   [Full Text] [Related]  

  • 7. Side effects of depot fluphenazines.
    Ayd FJ
    Adv Biochem Psychopharmacol; 1974; 9(0):301-9. PubMed ID: 4599435
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effects of depot fluphenazines.
    Ayd FJ
    Compr Psychiatry; 1974; 15(4):277-84. PubMed ID: 4607070
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Payquil convulsions" as a differential diagnosis in organic brain seizures in the terminal state of chronic kidney insufficiency].
    Lange H; Miller B
    Med Klin; 1968 Jan; 63(1):12-4. PubMed ID: 5668744
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal manifestations caused by metoclopramide. Apropos of 6 cases].
    Sicard JP; Reignier A; Bakouche P
    Nouv Presse Med; 1973 Jan; 2(1):31-2. PubMed ID: 4684764
    [No Abstract]   [Full Text] [Related]  

  • 11. NEUROLOGICAL EFFECTS OF TRIFLUPROMAZINE.
    DIKSHIT AK
    Indian Pediatr; 1964 Sep; 1():343-6. PubMed ID: 14214327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Extrapyramidal movement disorders following administration of flunarizine].
    Jongerius AM; van Gool AR
    Ned Tijdschr Geneeskd; 1989 Apr; 133(14):746-7. PubMed ID: 2716906
    [No Abstract]   [Full Text] [Related]  

  • 13. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extra-pyramidal syndrome caused by neuroleptics].
    Lambert PA
    Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of extrapyramidal adverse effects in neuroleptic therapy].
    Malm U
    Nord Psykiatr Tidsskr; 1972; 26(6):348-50. PubMed ID: 4634569
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological syndromes associated with antipsychotic drug use. A special report.
    Freedman DX
    Arch Gen Psychiatry; 1973 Apr; 28(4):463-7. PubMed ID: 4692143
    [No Abstract]   [Full Text] [Related]  

  • 17. The neuroleptic malignant syndrome.
    Kimsey LR; Gibbs JT; Glen RS; Markette JR; Kosted E
    Tex Med; 1983 Oct; 79(10):54-5. PubMed ID: 6138871
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent dyskinesia after long-term treatment with neuroleptics in Japan: its present status and clinical problems.
    Yagi G; Ogita K; Ohtsuka N; Itoh H; Miura S
    Keio J Med; 1976 Jan; 25(1):27-35. PubMed ID: 950737
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Metoclopramide and facial dyskinesia.
    Melmed S; Bank H
    Br Med J; 1975 Feb; 1(5953):331. PubMed ID: 1111802
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible neurologic manifestations after glycerol: a short report.
    Singh R; Lehl SS; Sachdev A; Sood A; Malhotra HS
    Neurol India; 2001 Sep; 49(3):320-1. PubMed ID: 11593257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.